Patientinnen mit Ovarialkarzinomrezidiv profitieren von neuen Therapiestrategien
Crossref DOI link: https://doi.org/10.1007/s15015-020-2491-2
Published Online: 2020-09-04
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Trillsch, Fabian
Mahner, Sven
Text and Data Mining valid from 2020-09-01
Version of Record valid from 2020-09-01
Article History
First Online: 4 September 2020